MF
MRTX

Magnetar Financial’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Magnetar Financial’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-834,390
Closed -$49M – 524
2023
Q4 		$49M Buy
+834,390
New +$46.9M 1.24% 24
2023
Q2 		– Sell
-21,875
Closed -$813K – 688
2023
Q1 		$813K Buy
+21,875
New +$984K 0.02% 412
2022
Q3 		– Sell
-7,807
Closed -$524 – 1663
2022
Q2 		$524 Sell
7,807
-6,098
-44% -$388K 0.01% 1134
2022
Q1 		$1.14M Buy
+13,905
New +$1.42M 0.01% 777
2021
Q3 		– Sell
-1,783
Closed -$288 – 1570
2021
Q2 		$288 Buy
+1,783
New +$286K ﹤0.01% 1038
2021
Q1 		– Sell
-3,719
Closed -$817K – 1221
2020
Q4 		$817K Buy
+3,719
New +$804K 0.01% 502
2020
Q1 		– Sell
-1,554
Closed -$200K – 678
2019
Q4 		$200K Buy
+1,554
New +$150K ﹤0.01% 497

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Magnetar Financial's MRTX Position: Q1 2024 in Review

Magnetar Financial sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 834,390 shares — an estimated $49M sold.

Magnetar Financial first reported a position in MRTX in Q4 2019 and held it in 7 quarters. The position peaked at $49M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Magnetar Financial reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Magnetar Financial sold 834,390 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $49M.
  • Magnetar Financial first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Magnetar Financial's Mirati Therapeutics, Inc. Common Stock position peaked at $49M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Magnetar Financial's 13F filing for Q1 2024, filed 15 May 2024.